Document ID: chunk:federal_register_of_legislation:F2025L00049:clause:10_9
Version: federal_register_of_legislation:F2025L00049
Segment Type: clause
Provision Reference: sch 10 cl 9
Character Range: 522374–523692

9  Poisons available only when prescribed or authorised in certain circumstances
  N, α -DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE *(MDMA) in preparations for human use may be supplied only for the treatment of post-traumatic stress disorder:
 (a) if MDMA is prescribed, or its supply is authorised, by a medical practitioner:
 (i) registered under State or Territory legislation that forms part of the Health Practitioner Regulation National Law as a specialist psychiatrist; and
 (ii) for whom an authority under subsection 19(5) of the Act that covers MDMA is in force; or
 (b) for use in a clinical trial that is approved by, or notified to, the Secretary under the Act.

  PSILOCYBINE in preparations for human use may be supplied only for the treatment of treatment-resistant depression:
 (a) if psilocybine is prescribed, or its supply is authorised, by a medical practitioner:
 (i) registered under State or Territory legislation that forms part of the Health Practitioner Regulation National Law as a specialist psychiatrist; and
 (ii) for whom an authority under subsection 19(5) of the Act that covers psilocybine is in force; or
 (b) for use in a clinical trial that is approved by, or notified to, the Secretary under the Act.

Appendix E—First aid instructions for poisons

Note: See section 31.